Proposed Data Collection Submitted for Public Comment and Recommendations, 95792-95793 [2024-28322]
Download as PDF
95792
Federal Register / Vol. 89, No. 232 / Tuesday, December 3, 2024 / Notices
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Public Health Ethics and
Regulations, Office of Science, Centers for
Disease Control and Prevention.
[FR Doc. 2024–28320 Filed 12–2–24; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–25–1363; Docket No. CDC–2024–
0097]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other federal
agencies to take this opportunity to
comment on a continuing information
collection, as required by the Paperwork
Reduction Act of 1995. This notice
invites comment on the Research Data
Center (RDC) Proposal for Access to
Confidential Data for the National
Center for Health Statistics (NCHS).
This data collection is used to assess
researcher’s request for access to
confidential NCHS data for their
research projects.
DATES: Written comments must be
received on or before February 3, 2025.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2024–
0097 by any of the following methods:
• Federal eRulemaking Portal:
www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS–H21–8, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. All relevant comments
received will be posted without change
to www.regulations.gov, including any
lotter on DSK11XQN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
17:09 Dec 02, 2024
Jkt 265001
personal information provided. For
access to the docket to read background
documents or comments received, go to
www.regulations.gov.
Please note: All public comment
should be submitted through the
Federal eRulemaking portal
(www.regulations.gov) or by U.S. mail to
the address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
H21–8, Atlanta, Georgia 30329;
Telephone: 404–639–7570; Email: omb@
cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
PO 00000
Frm 00061
Fmt 4703
Sfmt 4703
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
Proposed Project
Research Data Center (RDC) Proposal
for Access to Confidential Data for the
National Center for Health Statistics
(OMB Control No. 0920–1363, Exp. 4/
30/2025)—Extension—National Center
for Health Statistics (NCHS), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
Section 306(b)(4) of the Public Health
Service (PHS) Act (42 U.S.C. 242k(b)(4)),
as amended, authorizes the Secretary of
Health and Human Services (DHHS),
acting through NCHS, to receive
requests for providing data and statistics
to the public. NCHS receives requests
for confidential data from the public
through the Research Data Center (RDC)
Proposal for Access to Confidential
Data. This is a request for an Extension
without change from OMB to collect
information via the RDC proposal over
the next three years at an overall burden
rate of 990 hours.
As part of a comprehensive data
dissemination program, the Research
Data Center (RDC), National Center for
Health Statistics (NCHS), Centers for
Disease Control and Prevention,
requires prospective researchers who
need access to confidential data to
complete a research proposal.
Researchers self-select whether they
need access to confidential data to
answer their research questions. The
RDC requires the researcher to complete
a research proposal so NCHS
understands the research proposed,
whether confidential data are available
to address the research questions, how
the confidential data will be used and
what data outputs the researcher needs
to satisfy their project. The completed
proposal is sent to NCHS for
adjudication on whether the proposed
research is possible.
To capture the information needed to
adjudicate researchers’ need for access
to confidential NCHS data, this request
allows for both respondents and time
per response for a total estimated annual
burden total of 330 hours (990 hours for
a three-year clearance period). There is
no cost to respondents other than their
time to complete the proposal.
E:\FR\FM\03DEN1.SGM
03DEN1
95793
Federal Register / Vol. 89, No. 232 / Tuesday, December 3, 2024 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Avg. burden
per response
(in hrs.)
Total burden
(in hrs.)
Form name
Researcher ........................................
Research Data Center proposal ......
110
1
3
330
Total ...........................................
...........................................................
330
........................
........................
........................
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Public Health Ethics and
Regulations, Office of Science, Centers for
Disease Control and Prevention.
[FR Doc. 2024–28322 Filed 12–2–24; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[Docket No. CDC–2024–0100]
Draft CDC’s Recommendations for HIV
Screening in Clinical Settings
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice.
AGENCY:
The Centers for Disease
Control and Prevention in the
Department of Health and Human
Services announces the opening of a
docket to obtain comment on the draft
Recommendations for HIV Screening in
Clinical Settings, that update portions of
CDC’s ‘‘Revised Recommendations for
HIV Testing of Adults, Adolescents, and
Pregnant Women in Health-Care
Settings,’’ published in 2006.
DATES: Written comments must be
received on or before January 2, 2025.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2024–
0100 by either of the methods listed
below. Do not submit comments by
email. CDC does not accept comments
by email.
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: National Center for HIV, Viral
Hepatitis, STD, and TB Prevention,
CDC, 1600 Clifton Road NE, Mailstop
U.S. 8–6, Atlanta, GA 30329–4027.
Instructions: All submissions received
must include the agency name and
Docket Number. All relevant comments
received will be posted without change
to https://regulations.gov, including any
personal information provided. For
access to the docket to read background
documents or comments received, go to
https://www.regulations.gov.
SUMMARY:
lotter on DSK11XQN23PROD with NOTICES1
Number of
responses per
respondent
Number of
respondents
Type of respondents
VerDate Sep<11>2014
17:09 Dec 02, 2024
Jkt 265001
FOR FURTHER INFORMATION CONTACT:
Cecily Campbell, National Center for
HIV, Viral Hepatitis, STD, and TB
Prevention, CDC, 1600 Clifton Road NE,
Mailstop U.S. 8–6, Atlanta, GA 30329–
4027, Email: nchhstppolicy@cdc.gov.
Office phone: 404–639–0485.
SUPPLEMENTARY INFORMATION: CDC is
requesting public comment on the draft
‘‘Recommendations for HIV Screening
in Clinical Settings,’’ which is available
on regulations.gov in Docket CDC–
2024–0100. These recommendations
modify the ages for HIV screening
including eliminating an upper age
limit, encourage providers to use
clinical decision support tools such as
automated HIV test laboratory orders to
implement HIV screening, provide
considerations for healthcare
populations on which to conduct HIV
screening, recommend anyone who
requests a test should be tested, and
emphasize the use of a general consent
process as used for other routine tests.
CDC describes the methods and
supporting evidence in the
recommendations. The
recommendations’ objectives are to
diagnose and link patients with
undiagnosed infection to clinical care;
relink persons with previously
diagnosed HIV to clinical care; diagnose
HIV infection earlier; and reduce HIV
transmission in the United States.
Public Participation
Interested persons or organizations
are invited to participate by submitting
written views, recommendations, and
data. In addition, CDC invites comments
specifically on the following questions
proposed in this document:
• Does the evidence presented
support the proposed recommendations
for HIV screening in clinical settings,
including the benefits and harms of HIV
screening? If not, please state the reason
why and, if available, provide
additional evidence for consideration.
• Are CDC’s proposed
recommendations for HIV screening in
clinical settings clearly written? If not,
what changes do you propose to make
it clearer?
• If implemented as currently drafted,
do you believe these recommendations
would improve HIV screening in
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
clinical settings, improve diagnoses and
linking patients with undiagnosed
infection to clinical care; relinking
persons with previously diagnosed HIV
to clinical care; diagnosing HIV
infection earlier; and reducing HIV
transmission in the United States? If
not, please provide an explanation and
supporting data or evidence.
• How should CDC disseminate the
final recommendations to effectively
reach end users such as healthcare
providers in clinical settings?
• After the recommendations are
finalized, CDC is planning to publish an
implementation guide for healthcare
providers to supplement the updated
recommendations. What should the
implementation guide include?
Please note that comments received,
including attachments and other
supporting materials, are part of the
public record and are subject to public
disclosure. Comments will be posted on
https://www.regulations.gov. Therefore,
do not include any information in your
comment or supporting materials that
you consider confidential or
inappropriate for public disclosure. If
you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be on
public display. CDC will review all
submissions and may choose to redact,
or withhold, submissions containing
private or proprietary information such
as Social Security numbers, medical
information, inappropriate language, or
duplicate/near duplicate examples of a
mass-mail campaign. Do not submit
comments by email. CDC does not
accept comment by email.
After the comments received on the
draft are considered and addressed, the
final recommendations will be
published on CDC’s website at https://
www.cdc.gov/hiv/guidelines/
testing.html. The final recommendations
will also be posted to docket CDC–
2024–0100 at www.regulations.gov.
Background
Human immunodeficiency virus
(HIV) is a virus that attacks the body’s
immune system. The only way a person
can know their HIV status is by getting
tested (CDC, 2024a). While there is no
E:\FR\FM\03DEN1.SGM
03DEN1
Agencies
[Federal Register Volume 89, Number 232 (Tuesday, December 3, 2024)]
[Notices]
[Pages 95792-95793]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-28322]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-25-1363; Docket No. CDC-2024-0097]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
federal agencies to take this opportunity to comment on a continuing
information collection, as required by the Paperwork Reduction Act of
1995. This notice invites comment on the Research Data Center (RDC)
Proposal for Access to Confidential Data for the National Center for
Health Statistics (NCHS). This data collection is used to assess
researcher's request for access to confidential NCHS data for their
research projects.
DATES: Written comments must be received on or before February 3, 2025.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2024-
0097 by any of the following methods:
Federal eRulemaking Portal: www.regulations.gov. Follow
the instructions for submitting comments.
Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS-H21-8, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. All relevant comments received will be posted
without change to www.regulations.gov, including any personal
information provided. For access to the docket to read background
documents or comments received, go to www.regulations.gov.
Please note: All public comment should be submitted through the
Federal eRulemaking portal (www.regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS-H21-8, Atlanta, Georgia 30329; Telephone: 404-639-7570;
Email: [email protected].
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected;
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses; and
5. Assess information collection costs.
Proposed Project
Research Data Center (RDC) Proposal for Access to Confidential Data
for the National Center for Health Statistics (OMB Control No. 0920-
1363, Exp. 4/30/2025)--Extension--National Center for Health Statistics
(NCHS), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
Section 306(b)(4) of the Public Health Service (PHS) Act (42 U.S.C.
242k(b)(4)), as amended, authorizes the Secretary of Health and Human
Services (DHHS), acting through NCHS, to receive requests for providing
data and statistics to the public. NCHS receives requests for
confidential data from the public through the Research Data Center
(RDC) Proposal for Access to Confidential Data. This is a request for
an Extension without change from OMB to collect information via the RDC
proposal over the next three years at an overall burden rate of 990
hours.
As part of a comprehensive data dissemination program, the Research
Data Center (RDC), National Center for Health Statistics (NCHS),
Centers for Disease Control and Prevention, requires prospective
researchers who need access to confidential data to complete a research
proposal. Researchers self-select whether they need access to
confidential data to answer their research questions. The RDC requires
the researcher to complete a research proposal so NCHS understands the
research proposed, whether confidential data are available to address
the research questions, how the confidential data will be used and what
data outputs the researcher needs to satisfy their project. The
completed proposal is sent to NCHS for adjudication on whether the
proposed research is possible.
To capture the information needed to adjudicate researchers' need
for access to confidential NCHS data, this request allows for both
respondents and time per response for a total estimated annual burden
total of 330 hours (990 hours for a three-year clearance period). There
is no cost to respondents other than their time to complete the
proposal.
[[Page 95793]]
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Avg. burden
Type of respondents Form name Number of responses per per response Total burden
respondents respondent (in hrs.) (in hrs.)
----------------------------------------------------------------------------------------------------------------
Researcher.................... Research Data 110 1 3 330
Center proposal.
---------------------------------------------------------------------------------
Total..................... ................ 330 .............. .............. ..............
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health
Ethics and Regulations, Office of Science, Centers for Disease Control
and Prevention.
[FR Doc. 2024-28322 Filed 12-2-24; 8:45 am]
BILLING CODE 4163-18-P